ARMI BioIndustries is the full-service development, manufacturing and commercialization operation for the Advanced Regenerative Manufacturing Institute. We provide developers of engineered cells, tissues and organs a comprehensive range of services covering process development, deep tissue and material characterization, clinical manufacturing, regulatory and commercial support. ARMI BioIndustries leverages BioFabUSA’s Tissue Foundry concept, a 30,000-square-feet, state-of-the-art development center, and the extensive experience and expertise of ARMI’s scientists and engineers to enable the scalable, consistent and cost-effective manufacturing of engineered cells, tissues and organs.
Deep cell and tissue characterization is essential to the development of controlled manufacturing processes for living, cell-based products. ARMI built a Deep Tissue Characterization Center (DTCC) to address this critical need. The DTCC applies a multiomic approach to characterizing cells, tissues, organs and materials. It correlates clinical outcomes to quality attributes and process parameters. And it applies Quality by Design principles to the development of scalable, consistent processes.
Process Development Services
We offer process development specifically designed to meet the needs of regenerative manufacturing. The work conducted by this group is supported by our Deep Tissue Characterization Center, as well as our Tissue Foundry platform. It prioritizes process gaps analysis, simplification, optimization and eventual automation.